Algifor Dolo forte 200 mg / 5 ml

Algifor Dolo forte 200 mg / 5 ml is a medicine authorised by Swissmedic under authorisation number 65916. The authorisation holder is Verfora SA. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 22 September 2017 and the authorisation is valid without a time limit. ATC code M01AE01 places the medicine in the group Anti-inflammatory and antirheumatic products.

  • Dispensing category D
  • Authorisation number 65916
  • ATC M01AE01
  • Synthetic medicines
Authorisation data
Authorisation number65916
NameAlgifor Dolo forte 200 mg / 5 ml
Full nameAlgifor Dolo forte 200 mg / 5 ml, Suspension
Authorisation holderVerfora SA
Medicinal product codeSynthetic medicines
Dispensing categoryD · No prescription, with advice
ATC codeM01AE01
First authorisation22 September 2017
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Algifor Dolo forte 200 mg / 5 ml, SuspensionD22 September 2017
2Algifor Dolo forte 400 mg / 10 ml, SuspensionD22 September 2017

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
5100mlM01AE0107.10.1.D
610mlM01AE0107.10.1.D

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Algifor Dolo forte 200 mg / 5 ml authorised in Switzerland?

Yes. Algifor Dolo forte 200 mg / 5 ml is authorised by Swissmedic under authorisation number 65916, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Algifor Dolo forte 200 mg / 5 ml have?

Algifor Dolo forte 200 mg / 5 ml is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.

Who is the authorisation holder of Algifor Dolo forte 200 mg / 5 ml?

The authorisation holder is Verfora SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com